Alpha Tau Medical (DRTS) Other Accumulated Expenses (2020 - 2026)
Alpha Tau Medical (DRTS) posted quarterly Other Accumulated Expenses of $5.5 million for Q1 2026, down 10.65% year-on-year from $6.2 million in Q1 2025, and little changed on a QoQ basis from $5.5 million in Q4 2025.
Alpha Tau Medical (DRTS) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Other Accumulated Expenses for 7 consecutive years, with $5.5 million the latest figure, recorded in Q1 2026.
- Quarterly Other Accumulated Expenses fell 10.65% year-over-year to $5.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (down 10.65% YoY) and the FY2025 annual result came in at $5.5 million, up 33.27% from the prior year.
- Other Accumulated Expenses held at $5.5 million in Q1 2026 per DRTS's latest filing, from $5.5 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for DRTS reached as high as $6.2 million in Q1 2025 and fell as low as $1.6 million in Q2 2022.
- A 5-year average of $3.6 million and a median of $3.4 million in 2024 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses decreased 29.86% — and 2023, when it surged 77.47%.
- Year by year, Other Accumulated Expenses stood at $2.2 million in 2022, then soared by 54.67% to $3.5 million in 2023, then grew by 18.97% to $4.1 million in 2024, then jumped by 33.27% to $5.5 million in 2025, then advanced by 0.38% to $5.5 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $5.5 million, $5.5 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Alpha Tau Medical | 1.16 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.53 Mn |
| Dec 31, 2025 | 5.51 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Mar 31, 2025 | 6.19 Mn |
| Dec 31, 2024 | 4.13 Mn |
| Sep 30, 2024 | 2.82 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 3.12 Mn |
| Jun 30, 2023 | 2.78 Mn |
| Mar 31, 2023 | 2.43 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 1.57 Mn |
| Mar 31, 2022 | 2.47 Mn |
| Dec 31, 2021 | 3.20 Mn |
| Dec 31, 2020 | 1.12 Mn |